Successful haploidentical transplantation using plasma exchange and post-transplantation cyclophosphamide for severe aplastic anemia patients with anti-human leukocyte antigen donor-specific antibodies

Chen J, Lee V, Luo CJ, Chiang AK, Hongeng S, Tan PL, Tan AM, Sanpakit K, Li CF, Lee AC, Chua HC, Okamoto Y (2013) Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group. Br J Haematol 162(3):383–391. https://doi.org/10.1111/bjh.12405 Dufour C, Veys P, Carraro E, Bhatnagar N, Pillon M, Wynn R, Gibson B, Vora AJ, Steward CG, Ewins AM, Hough RE, de la Fuente J, Velangi M, Amrolia PJ, Skinner R, Bacigalupo A, Risitano AM, Socie G, Peffault de Latour R, Passweg J, Rovo A, Tichelli A, Schrezenmeier H, Hochsmann B, Bader P, van Biezen A, Aljurf MD, Kulasekararaj A, Marsh JC, Samarasinghe S (2015) Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT. Br J Haematol 171(4):585–594. https://doi.org/10.1111/bjh.13614 Zhang P, Feng K, Xue Y, Zhang CX, Wang Y, Li XL (2017) Clinical applications of haploidentical hematopoietic stem cell transplantation in severe aplastic anemia. Eur Rev Med Pharmacol Sci 21(1):155–161 Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R, Scheinberg P, Savage S, Maciejewski JP, Tiu RV, DiFronzo N, Horowitz MM, Antin JH (2011) Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010. Biol Blood Marrow Transplant 17(3):291–299. https://doi.org/10.1016/j.bbmt.2010.10.028 Xu LP, Jin S, Wang SQ, Xia L-H, Bai H, Gao S-J, Liu Q-F, Wang J-M, Wang X, Jiang M, Zhang X, Wu D-P, Huang X-J (2017) Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol 10(25):25–34. https://doi.org/10.1186/s13045-017-0398-y Appelbaum FR (2014) Alternative donor transplantation for adults with acute leukemia. Best Pract Res Clin Haematol 27(3-4):272–277. https://doi.org/10.1016/j.beha.2014.10.009 Ruggeri A, Ciceri F, Glukman E, Labopin M, Rocha V (2010) Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: umbilical cord blood or haploidentical donors? Best Pract Clin Res Haematol 23:207–216. https://doi.org/10.1016/j.beha.2010.06.002 Detrait M, Dubois V, Sobh M, Morisset S, Tedone N, Labussière H, Lilia Gillis L, Barraco F, Cannas G, Ducastelle S, Fatoum J, Thomas X, Chelgoum Y, Nicolini FE, Mauricette Michallet M (2012) Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens. Exp Hematol 40(10):792–799. https://doi.org/10.1016/j.exphem.2012.06.003 Yoshihara S, Maruya E, Taniguchi K, Kaida K, Kato R, Inoue T, Fujioka T, Tamaki H, Ikegame K, Okada M, Soma T, Hayashi K, Fujii N, Onuma T, Kusunoki Y, Saji H, Ogawa H (2012) Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT. Bone Marrow Transplant 47(4):508–515. https://doi.org/10.1038/bmt.2011.131 Morin-Zorman S, Loiseau P, Taupin JL, Caillat-Zucman S (2016) Donor-specific anti-HLA antibodies in allogeneic hematopoietic stem cell transplantation. Front Immunol 12(7):307–312. https://doi.org/10.3389/fimmu.2016.00307 Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED (1995) 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 15(6):825–828 Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME (2015) National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: the 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant 21(3):945–956. https://doi.org/10.1016/j.bbmt.2014.12.001 Xu LP, Xu ZL, Wang FR, Mo XD, Han TT, Han W, Chen YH, Zhang YY, Wang JZ, Wang Y, Yan CH, Sun YQ, Tang FF, Zhang XH, Huang XJ (2018) Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia. Bone Marrow Transplant 53(2):188–192. https://doi.org/10.1038/bmt.2017.237 Esteves I, Bonfim C, Pasquini R, Funke V, Pereira NF, Rocha V, Novis Y, Arrais C, Colturato V, de Souza MP, Torres M, Fernandes JF, Kerbauy FR, Ribeiro AAF, Santos FPS, Hamerschlak N (2015) Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study. Bone Marrow Transplant 50(5):685–689. https://doi.org/10.1038/bmt.2015.20 Ciurea SO, de Lima M, Cano P, Korbling M, Giralt S, Shpall EJ, Wang XM, Thall PF, Champlin RE, Fernandez-Vina M (2009) High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation 88(8):1019–1024. https://doi.org/10.1097/TP.0b013e3181b9d710 Chang YJ, Zhao XY, Xu LP, Zhang XH, Wang Y, Han W, Chen H, Wang FR, Mo XD, Zhang YY, Huo MR, Zhao XS, Kong Y, Liu KY, Huang XJ (2015) Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets. J Hematol Oncol 8:84–93. https://doi.org/10.1186/s13045-015-0182-9 Morin-Zorman S, Loiseau P, Taupin JL, Caillat-Zucman S (2016) Donor-specific anti-HLA antibodies in allogeneic hematopoietic stem cell transplantation. Front Immunol 7:1–6. https://doi.org/10.3389/fimmu.2016.00307 Ciurea SO, Thall PF, Milton DR, Barnes TH, Kongtim P, Carmazzi Y, López AA, Yap DY, Popat U, Rondon G, Lichtiger B, Aung F, Afshar-Kharghan V, Ma Q, Fernández-Viña M, Champlin RE, Cao K (2015) Complement-binding donor-specific anti-HLA antibodies and risk of primary graft failure in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 21(8):1392–1398. https://doi.org/10.1016/j.bbmt.2015.05.001 Piyanuch K, Kai C, Ciurea SO (2016) Donor specific anti-HLA antibody and risk of graft failure in haploidentical stem cell transplantation. Adv Hematol 2016:1–10. https://doi.org/10.1155/2016/4025073 Zachary AA, Leffell MS (2014) Desensitization for solid organ and hematopoietic stem cell transplantation. Immunol Rev 258:183–207. https://doi.org/10.1111/imr.12150 Luznik L, O’Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, Gooley TA, Piantadosi S, Kaup M, Ambinder RF, Huff CA, Matsui W, Bolaños-Meade J, Borrello I, Powell JD, Harrington E, Warnock S, Flowers M, Brodsky RA, Sandmaier BM, Storb RF, Jones RJ, Fuchs EJ (2008) HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 14(6):641–650. https://doi.org/10.1016/j.bbmt.2008.03.005 Bashey A, Zhang X, Sizemore CA, Manion K, Brown S, Holland HK, Morris LE, Solomon SR (2013) T cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unelated donor transplantation. J Clin Oncol 31(10):1310–1316. https://doi.org/10.1200/JCO.2012.44.3523